ATE354588T1 - Verfahren und zusammestellungen zum nachweis und behandlung von brustkrebs, beruhend auf brustkrebs-assoziierten polypeptiden - Google Patents

Verfahren und zusammestellungen zum nachweis und behandlung von brustkrebs, beruhend auf brustkrebs-assoziierten polypeptiden

Info

Publication number
ATE354588T1
ATE354588T1 AT00979182T AT00979182T ATE354588T1 AT E354588 T1 ATE354588 T1 AT E354588T1 AT 00979182 T AT00979182 T AT 00979182T AT 00979182 T AT00979182 T AT 00979182T AT E354588 T1 ATE354588 T1 AT E354588T1
Authority
AT
Austria
Prior art keywords
breast cancer
methods
compositions
detecting
provides
Prior art date
Application number
AT00979182T
Other languages
English (en)
Inventor
Brynmor Watkins
Robert P Szaro
Original Assignee
Matritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matritech Inc filed Critical Matritech Inc
Application granted granted Critical
Publication of ATE354588T1 publication Critical patent/ATE354588T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00979182T 1999-11-16 2000-11-16 Verfahren und zusammestellungen zum nachweis und behandlung von brustkrebs, beruhend auf brustkrebs-assoziierten polypeptiden ATE354588T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16567399P 1999-11-16 1999-11-16
US17217099P 1999-12-17 1999-12-17
US17886000P 2000-01-27 2000-01-27
US20172100P 2000-05-03 2000-05-03
US09/709,947 US6936424B1 (en) 1999-11-16 2000-11-10 Materials and methods for detection and treatment of breast cancer

Publications (1)

Publication Number Publication Date
ATE354588T1 true ATE354588T1 (de) 2007-03-15

Family

ID=30449666

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00979182T ATE354588T1 (de) 1999-11-16 2000-11-16 Verfahren und zusammestellungen zum nachweis und behandlung von brustkrebs, beruhend auf brustkrebs-assoziierten polypeptiden

Country Status (9)

Country Link
US (2) US6936424B1 (de)
EP (2) EP1240521A2 (de)
JP (2) JP2004500056A (de)
AT (1) ATE354588T1 (de)
AU (2) AU1658901A (de)
CA (2) CA2391212A1 (de)
DE (1) DE60033555T2 (de)
ES (1) ES2282149T3 (de)
WO (2) WO2001036470A2 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936424B1 (en) * 1999-11-16 2005-08-30 Matritech, Inc. Materials and methods for detection and treatment of breast cancer
AUPQ886100A0 (en) * 2000-07-19 2000-08-10 Biotron Limited Diagnostic test
CA2320549A1 (en) * 2000-09-25 2002-03-25 Eastern Virginia Medical College Biomarkers of transitional cell carcinoma of the bladder
KR20040039277A (ko) * 2001-08-03 2004-05-10 바이오트론 리미티드 신규 암 마커 및 암 진단에서의 그의 용도
US6756586B2 (en) 2001-10-15 2004-06-29 Vanderbilt University Methods and apparatus for analyzing biological samples by mass spectrometry
WO2003054549A2 (en) * 2001-12-08 2003-07-03 Micromass Uk Limited Method of mass spectrometry
DE10296200D2 (de) * 2001-12-21 2004-11-04 Biovision Ag Verfahren zur Diagnose von Brustkrebserkrankungen, zugehörige Peptide und deren Verwendungen
EP1585962A4 (de) * 2002-03-06 2009-03-18 Univ Johns Hopkins Verwendung von biomarkern zum nachweis von brustkrebs
AU2002950878A0 (en) * 2002-08-20 2002-09-12 Proteome Systems Intellectual Property Pty Ltd Method for diagnosing disorders
MXPA05006382A (es) 2002-12-20 2005-10-24 Hoffmann La Roche Uso de nicotinamida n-metiltransferasa como un marcador para cancer colorrectal.
EP1613966A2 (de) 2003-04-08 2006-01-11 Colotech A/S Verfahren zum nachweis von kolorektalem krebs in menschlichen proben
US7425700B2 (en) 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
US20050112622A1 (en) * 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
US20050037331A1 (en) * 2003-08-13 2005-02-17 William Galbraith Apparatuses and methods for reducing albumin in samples
GB0320648D0 (en) * 2003-09-03 2003-10-01 Randox Lab Ltd Molecular marker
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
WO2006034278A2 (en) * 2004-09-21 2006-03-30 Matritech, Inc. Methods and compositions for detecting cancer using components of the u2 spliceosomal particle
WO2006065960A2 (en) * 2004-12-14 2006-06-22 Applera Corporation Cationic liposomes comprising a charge neutral compound and a cationic phospholipid
CA2593184A1 (en) 2005-01-06 2006-07-13 Eastern Virginia Medical School Apolipoprotein a-ii isoform as a biomarker for prostate cancer
DE602006013109D1 (de) * 2005-03-14 2010-05-06 Japan Health Science Found Markerprotein zur verwendung bei der diagnose von bauchspeicheldrüsenkrebs
US7648844B2 (en) 2005-05-02 2010-01-19 Bioscale, Inc. Method and apparatus for detection of analyte using an acoustic device
US7300631B2 (en) 2005-05-02 2007-11-27 Bioscale, Inc. Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles
US7749445B2 (en) 2005-05-02 2010-07-06 Bioscale, Inc. Method and apparatus for analyzing bioprocess fluids
US7611908B2 (en) 2005-05-02 2009-11-03 Bioscale, Inc. Method and apparatus for therapeutic drug monitoring using an acoustic device
WO2007002069A2 (en) * 2005-06-21 2007-01-04 Anthony Goncalves Serum biomarkers for breast cancer
EP1934603A4 (de) * 2005-09-19 2010-01-06 Univ Johns Hopkins Biomarker für prostatakrebs
EP1941280A2 (de) * 2005-10-13 2008-07-09 Applera Corporation Verfahren zur entwicklung eines biomolekültests
WO2008039482A2 (en) * 2006-09-26 2008-04-03 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
US9517240B2 (en) 2006-09-26 2016-12-13 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
WO2009033056A1 (en) 2007-09-06 2009-03-12 Bioscale, Inc. Reusable detection surfaces and methods of using same
WO2009075864A1 (en) * 2007-12-11 2009-06-18 New York University School Of Medicine Methods for detecting colon carcinoma
US9029530B2 (en) * 2009-01-02 2015-05-12 Biomarin Pharmaceutical Inc. Detection of oligosaccharides
US8809009B2 (en) 2009-01-02 2014-08-19 Biomarin Pharmaceutical Inc. Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
US8232073B2 (en) * 2009-01-02 2012-07-31 Zacharon Pharmaceuticals, Inc. Quantification of non-reducing end glycan residual compounds
EP2467499A1 (de) * 2009-08-21 2012-06-27 Oncotherapy Science, Inc. Cstf2 für zielgene zur lungenkrebstherapie und -diagnose
US8455624B2 (en) 2011-06-03 2013-06-04 University Of South Alabama Methods and compositions for detecting endometrial or ovarian cancer
US20170367584A1 (en) * 2015-02-11 2017-12-28 Abbott Diabetes Care Inc. Methods, Devices and Systems for Distinguishing Cancerous and Non-Cancerous Tissue
EP3387430A4 (de) * 2015-12-11 2019-08-14 Expression Pathology, Inc. Srm/mrm-tests
EP4368104A3 (de) * 2017-04-28 2024-09-25 Masimo Corporation Punktprüfmesssystem
CN107677825B (zh) * 2017-10-06 2019-04-23 汉氏联合（天津）干细胞研究院有限公司 一种用于宫颈癌诊断的肿瘤诊断组合物和用于制备诊断试剂盒的用途
CN117169534A (zh) 2019-08-05 2023-12-05 禧尔公司 用于样品制备、数据生成和蛋白质冠分析的系统和方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264550A (en) 1985-04-15 1993-11-23 Scios Nova Inc. Human anti-inflammatory phospholipase inhibitor protein
US5561222A (en) 1989-11-15 1996-10-01 Duke University RNA-binding proteins useful for the control of cellular genetic processing and expression
EP0460607A3 (en) * 1990-06-05 1992-04-01 Bristol-Myers Squibb Company Novel monoclonal antibody to novel antigen associated with human tumors
US5792664A (en) 1992-05-29 1998-08-11 The Rockefeller University Methods for producing and analyzing biopolymer ladders
EP0700521B1 (de) 1993-05-28 2003-06-04 Baylor College Of Medicine Verfahren und massenspektrometer zur desorption und ionisierung von analyten
NZ306653A (en) 1995-03-23 1999-03-29 Immunex Corp Isolated dna il-17 receptors
EP0787208A1 (de) 1995-07-03 1997-08-06 Akzo Nobel N.V. Ein verfahren zur bestimmung der integrität von nukleinsäuren
US5962242A (en) 1995-09-19 1999-10-05 Immuna Care Corporation Methods of predicting estrogen-dependent osteopenia
ATE234469T1 (de) 1996-08-13 2003-03-15 Biovision Ag Verfahren zur erfassung des status eines organismus durch messung von peptiden
DE19632521A1 (de) 1996-08-13 1998-02-19 Forssmann Wolf Georg Verfahren zur Gewinnung von Peptiden aus Köperflüssigkeiten und Geweben sowie Zellüberständen und zur Identifikation von krankheitsrelevanten Peptidmarkern
US5798266A (en) 1996-08-27 1998-08-25 K-Quay Enterprises, Llc Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer
US7008778B1 (en) * 1997-02-03 2006-03-07 Human Genome Sciences, Inc. Breast cancer specific gene 1
JP2001523096A (ja) 1997-03-21 2001-11-20 エム ユー エス シー ファンデーション フォーリサーチ ディベロップメント 乳癌の診断および治療のための方法ならびに組成物
NZ516848A (en) 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
WO1999039204A1 (en) 1998-02-02 1999-08-05 Novadx Removal of abundant interfering proteins from a liquid sample using a collapsible affinity matrix
US6410692B2 (en) 1998-02-02 2002-06-25 Novadx, Inc. Removal of abundant interfering proteins from a liquid sample using a collapsible affinity matrix
US6020135A (en) 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
US6753314B1 (en) * 1999-04-01 2004-06-22 Curagen Corporation Protein-protein complexes and methods of using same
US6936424B1 (en) * 1999-11-16 2005-08-30 Matritech, Inc. Materials and methods for detection and treatment of breast cancer
WO2006034278A2 (en) * 2004-09-21 2006-03-30 Matritech, Inc. Methods and compositions for detecting cancer using components of the u2 spliceosomal particle

Also Published As

Publication number Publication date
DE60033555D1 (de) 2007-04-05
DE60033555T2 (de) 2007-11-29
WO2001036470A3 (en) 2002-01-24
EP1240521A2 (de) 2002-09-18
WO2001036977A3 (en) 2001-11-22
JP2004500056A (ja) 2004-01-08
AU1658901A (en) 2001-05-30
EP1232177B1 (de) 2007-02-21
WO2001036977A2 (en) 2001-05-25
ES2282149T3 (es) 2007-10-16
WO2001036470A2 (en) 2001-05-25
US6936424B1 (en) 2005-08-30
EP1232177A2 (de) 2002-08-21
CA2390607A1 (en) 2001-05-25
WO2001036977A8 (en) 2002-01-24
US20060160154A1 (en) 2006-07-20
AU1615201A (en) 2001-05-30
CA2391212A1 (en) 2001-05-25
JP2003528296A (ja) 2003-09-24

Similar Documents

Publication Publication Date Title
ATE354588T1 (de) Verfahren und zusammestellungen zum nachweis und behandlung von brustkrebs, beruhend auf brustkrebs-assoziierten polypeptiden
ATE332505T1 (de) Verfahren und zusammensetzung zur auffindung von cervix-krebs
ATE223727T1 (de) Erkennung und modulierung von iaps und naip zur diagnose und behandlung von proliferativen erkrankungen
ATE437369T1 (de) Enzymkatalysierte metalldeposition zum verstärkten in-situ-nachweis von immunhistologischen epitopen und nukleinsäuresequenzen
EP1687283A4 (de) Für die bestimmung von fk506 geeignetes verfahren und zusammensetzung
IL124322A0 (en) Detection of an entity in a sample
ATE431853T1 (de) Auf oligonukleotid-modifizierten partikeln basierende bio-strichcodes
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
ATE222254T1 (de) Verwendung von einem metalloporphyrinkonjugat für den nachweis biologischer verbindungen
ATE416674T1 (de) Nachweis von verunreinigungen mittels selbstständiger einheiten die zielmaterialbindende farbstoffe gebrauchen
DE69942451D1 (de) Methode zum schnellen identifizieren von kleinen organischen liganden
DE60129151D1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
WO1995016919A3 (en) Methods and compositions for the detection of colon cancers
DK0757723T3 (da) Genetiske ændringer, der korrelerer med lungecarcinoma
WO2003033731A3 (en) Methods for detecting ovarian cancer
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
ATE321886T1 (de) Oligonukleotide und diese enthaltende komplexe zur detektion der anwesenheit oder abwesenheit einer zielnukleinsäure in einer probe
ATE487792T1 (de) Verfahren und zusammensetzungen zur identifikation von rna-bindenden proteinen
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
ATE233405T1 (de) Verfahren zur detektierung eines biologischen materials, eingangphase, detektionsphase und diese enthaltende reagenz
DE60010323D1 (de) Fluoreszenzkorrelationsspektroskopie zur identifizierung von verbindung-ziel-bindung
ATE489623T1 (de) Peptide zum nachweis von ehrlichia ewingii antikörper
DE60335387D1 (de) Zusammensetzungen und deren verwendungen zur identifizierung und zum targetting von provasopressinexprimierenden krebszellen
WO2002078636A3 (en) Detection and treatment of colorectal cancer
ATE353544T1 (de) Verwendung des proteins masp als marker für kolorektale karzinome

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties